CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Rosen Law Firm is reminding purchasers of Capricor Therapeutics securities between December 17, 2025 and July 26, 2026 of the September 28, 2026 deadline to move for lead plaintiff status in a securities fraud class action. The lawsuit alleges Capricor changed the pre-specified statistical analysis plan for its Deramiocel cell therapy without FDA agreement before resubmitting the BLA, creating what plaintiffs call a substantial risk to approval for Duchenne muscular dystrophy.
Key figures
- Loss threshold
- $100K
- Class certified
- No
- Class period end
- 2026-07-26
- Class period start
- 2025-12-17
- Lead plaintiff deadline
- 2026-09-28
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.